AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

πŸ‡ΏπŸ‡¦

Atovaquone in South Africa

12 products registered with SAHPRA β€” 7 active

Brand / ProductReg. No.HolderStatusExpires
ATOVAQUONE/PROGUANIL 250/100 mg GLENMARK53/20.2.6/0615Glenmark Pharmaceuticals South Africa (Pty) Ltdactive29 Oct 2029
FALCIRONE46/20.2.6/0025Cipla Medpro (Pty) Ltdsuspended17 Jul 2025
NUMAL46/20.2.6/0027Cipla Medpro (Pty) Ltdsuspended17 Jul 2025
WELLVONE SUSPENSION31/20.2.6/0033ACINO PHARMA (PTY) LTDsuspended22 Dec 2023
ATAPRO 62,5/25 mg PAEDIATRIC TABLET48/20.2.6/0675Specpharm (Pty) Ltdsuspended3 Nov 2022
ATAPRO 250/100 mg TABLET48/20.2.6/0674Specpharm (Pty) Ltdsuspended3 Nov 2022
HETOVANIL 62,5/25 mg48/20.2.6/0526Hetero Drugs South Africa (Pty) Ltdactive1 Jan 1900
MALANIL PAEDIATRICA40/20.2.6/0165ACINO PHARMA (PTY) LTDactive1 Jan 1900
MOZITEC47/20.2.6/1014Activo Health (Pty) Ltdactive1 Jan 1900
HETOVANIL 250/100 mg48/20.2.6/0527Hetero Drugs South Africa (Pty) Ltdactive1 Jan 1900
MALATEQ47/20.2.6/1015Forrester Pharma (Pty) Ltdactive1 Jan 1900
MALANIL37/20.2.6/0075ACINO PHARMA (PTY) LTDactive1 Jan 1900

Atovaquone β€” SAHPRA Registration Details

SAHPRA (South Africa) has 12 registered products containing Atovaquone, of which 7 are currently active. Data is sourced directly from the official SAHPRA drug register and refreshed daily.

Track Atovaquone registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.

Atovaquone β€” South Africa (SAHPRA) | AfricaRegulatory